What are the differences in treatment for cluster headaches, tension headaches, and migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Differences: Cluster vs Tension vs Migraine Headaches

The treatment approaches for these three headache types are fundamentally distinct: cluster headaches require high-flow oxygen (12 L/min) or subcutaneous sumatriptan for acute attacks with galcanezumab for prevention; migraines respond to triptans, gepants, or aspirin-acetaminophen-caffeine combinations acutely with multiple preventive options including topiramate, valproate, and CGRP inhibitors; tension-type headaches are managed with simple analgesics like ibuprofen (400 mg) or acetaminophen (1000 mg) acutely and amitriptyline for chronic prevention. 1, 2

Cluster Headache Treatment

Acute Management

  • First-line acute treatment is 100% oxygen at 12 L/min via non-rebreather mask for 15 minutes, achieving pain relief in 78% of patients compared to 20% with placebo 2
  • Subcutaneous sumatriptan 6 mg provides rapid relief, with 49% experiencing relief within 10 minutes and 74-75% within 15 minutes 2
  • Intranasal zolmitriptan 10 mg serves as an alternative to subcutaneous sumatriptan 2
  • Critical pitfall: oxygen flow rates below 12 L/min are insufficient—proper equipment and adequate flow rates are essential for effectiveness 2

Preventive Management

  • Galcanezumab is the first-line prophylactic treatment for episodic cluster headache based on the strongest available evidence 2
  • Verapamil is commonly used but lacks strong evidence for formal recommendation 2
  • Important caveat: galcanezumab is NOT effective for chronic cluster headache and should not be prescribed for this population 2
  • Preventive medications may require 2-3 months to become effective 2

Additional Options

  • Noninvasive vagus nerve stimulation is suggested for episodic cluster headache, particularly when medical treatment is contraindicated or side effects are intolerable 2, 3
  • Avoid oral ergot alkaloids, opioids, or barbiturates due to poor efficacy, potential toxicity, and dependency risks 2

Migraine Treatment

Acute Management

  • Primary care clinicians should consider triptans, aspirin-acetaminophen-caffeine combinations, and CGRP inhibitors (gepants) as first-line options for acute migraine treatment 1
  • Newer ditans block CGRP release by binding to 5-HT1F receptors, offering an alternative mechanism to triptans 1

Preventive Management for Episodic Migraine

  • Effective preventive medications include angiotensin-receptor blockers, lisinopril, topiramate, valproate, eptinezumab, and atogepant 1
  • Propranolol (80-240 mg/day) and timolol (20-30 mg/day) have consistent evidence for efficacy 1
  • Amitriptyline (30-150 mg/day) is the most studied antidepressant with consistent support for prevention 1
  • Divalproex sodium and sodium valproate have good evidence, though adverse events include weight gain, hair loss, tremor, and teratogenic potential 1
  • Gabapentin is NOT recommended for prevention of episodic migraine 1

Chronic Migraine Prevention

  • AbobotulinumtoxinA can be used for prevention of chronic migraine but NOT episodic migraine 1

Non-Pharmacologic Approaches

  • Aerobic exercise or physical therapy can be used in migraine management 1

Tension-Type Headache Treatment

Acute Management

  • Ibuprofen 400 mg and acetaminophen 1000 mg are first-line treatments for acute tension-type headache 1
  • NSAIDs are the mainstay of acute treatment 4

Preventive Management

  • Amitriptyline is recommended for prevention of chronic tension-type headache 1
  • Tricyclic antidepressants have the most evidence as prophylactic therapy 4

Non-Pharmacologic Approaches

  • Aerobic exercise or physical therapy can be used in tension-type headache management 1

Key Distinguishing Clinical Features

Cluster Headache Characteristics

  • Strictly unilateral, severe pain lasting 15-180 minutes with prominent ipsilateral autonomic symptoms including lacrimation, nasal congestion, and ptosis 3
  • Often triggered by alcohol and strong smells 3

Tension-Type Headache Characteristics

  • Bilateral with pressing, tightening, or non-pulsatile character, mild to moderate severity 5
  • Not aggravated by routine physical activity 5
  • Lacks nausea/vomiting, though may have anorexia; typically doesn't have both photophobia and phonophobia 5

Migraine Characteristics

  • Often unilateral, throbbing character, moderate to severe intensity 5
  • Worsens with activity 5
  • Associated with nausea/vomiting and photophobia/phonophobia 5

Critical Treatment Pitfalls

  • For cluster headaches, never use inadequate oxygen flow rates—12 L/min minimum is essential 2
  • Do not prescribe galcanezumab for chronic cluster headache—it only works for episodic cluster 2
  • Do not use abobotulinumtoxinA for episodic migraine—it is only effective for chronic migraine 1
  • Do not use gabapentin for episodic migraine prevention—evidence does not support this 1
  • Always rule out secondary headache causes before confirming primary headache diagnosis, particularly with red flags such as sudden onset, fever, focal neurological symptoms, or onset after age 50 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cluster Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Treatment of Hemicrania Continua and Cluster Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Migraine and Tension-Type Headache.

Seminars in neurology, 2018

Guideline

Tension Headache Characteristics and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.